Comprehensive Study Guide for Eye Anatomy, Assessment, and Disorders

Eye Anatomy and Essential Physiology

• External Structures and Protections

  • Eyelids: Function to protect the eye from injury, excessive light, and debris. They are responsible for spreading tears evenly across the ocular surface.

  • Cranial Nerve III (Oculomotor): Controls the opening of the eyelids.

  • Eyelashes: Act as traps for particles and debris.

  • Conjunctiva: A thin, transparent mucous membrane that covers the sclera and the inner surfaces of the eyelids. It produces mucus and tears for lubrication.

  • Conjunctivitis: Inflammation of the conjunctiva, commonly referred to as "pink eye."

  • Lacrimal Apparatus (Lacrimal Gland): Produces the tears necessary for eye moisture.

• Fibrous and Vascular Layers

  • Sclera: The white, outer protective layer of the eye.

  • Cornea: A transparent, dome-shaped anterior surface. It is an avascular structure (no circulation) and is nourished by tears and the aqueous humor.

  • Iris: The colored part of the eye that controls the size of the pupil.

  • Pupil: The central opening of the eye.

• Autonomic Control of the Pupil

  • Parasympathetic System: Stimulates pupil constriction, a process known as Miosis.

  • Sympathetic System: Stimulates pupil dilation, a process known as Mydriasis. This allows more light in during "fight or flight" scenarios to improve situational awareness.

  • Clinical Pearl: A fixed, dilated pupil can indicate increased intracranial pressure (ICP), central nervous system (CNS) issues, or compression of Cranial Nerve III.

• Internal Eye Structures and Fluids

  • Ciliary Body: Produces aqueous humor and controls the shape of the lens.

  • Lens: A transparent structure that focuses light onto the retina. It loses elasticity with age, leading to Presbyopia.

  • Aqueous Humor: Clear intraocular fluid located in the anterior and posterior chambers. It maintains Intraocular Pressure (IOP).

    • Normal IOP Range: $10-21\,mmHg$.

    • Glaucoma: Occurs when this fluid fails to drain properly, causing pressure to rise.

  • Vitreous Humor: A gel-like substance filling the posterior cavity behind the lens.

  • Choroid: The highly vascular middle layer that nourishes the retina.

  • Retina: Light-sensitive layer responsible for processing visual information.

  • Macula: The central area of the retina responsible for sharp, detailed central vision.

    • Age-Related Macular Degeneration (AMD): Degeneration of the macula resulting in loss of central vision.

  • Optic Disc: The nerve head where visual information is transmitted to the brain.

    • Papilledema: Swelling of the optic disc, which is a sign of increased intracranial pressure.

  • Optic Nerve (Cranial Nerve II): Transmits information to the occipital lobe for visual processing.

Cranial Nerves and Eye Movement

• Extraocular Muscles: There are six muscles around the eye orbit that coordinate movement.

• Cranial Nerve III (Oculomotor): Responsible for most eye movements, eyelid elevation, and pupil constriction.

• Cranial Nerve IV (Trochlear): Controls downward and inward eye movement.

• Cranial Nerve VI (Abducens): Controls lateral eye movement.

• Cranial Nerve III Palsy: Can manifest as ptosis (drooping eyelid), a dilated fixed pupil, and a "down and out" eye position.

Vision Assessment and Diagnostic Tests

• Visual Acuity Testing

  • Measures the clarity of central vision, which depends on the macula and Cranial Nerve II integrity.

  • Snellen Chart: Used for adults; the patient stands $20\,feet$ (or $6\,meters$) away.

  • Tumbling E Chart: Used for children or individuals who are non-literate or do not know the language.

  • Procedure: Patient wears their usual glasses, covers one eye at a time, and the weaker eye is tested first. The patient must read the smallest line where at least half the letters are identified correctly.

  • Interpretations:

    • $20/20$: Normal vision.

    • $20/30$: Referral normally needed.

    • $20/200$: Legal blindness.

• Color Vision and Pediatric Screening

  • Ishihara Plates: Used to detect color blindness, specifically red-green blindness, which is an X-linked recessive trait more common in males.

  • Red Reflex Test: Screening for cataracts and retinoblastoma.

  • Leukocoria: An absent or white reflex (white pupil) instead of the normal red reflex. This is a critical sign of Retinoblastoma (cancer).

  • Corneal Light Reflex: Used for assessing eye alignment and strabismus.

  • PERRLA: Pupils are Equal, Round, Reactive to Light and Accommodation (tests Cranial Nerve III).

• Advanced Diagnostics

  • Ophthalmoscopy: Examines the retina, optic disc, and macula. Can identify papilledema, diabetic retinopathy (hemorrhages/exudates), and cupping of the optic disc (glaucoma).

  • Tonometry: Measures intraocular pressure (Normal: $10-21\,mmHg$). High pressure indicates glaucoma.

Clinical Procedures and Medication Administration

• Eye Irrigation

  • Used to flush out chemical substances, foreign bodies, or irritants.

  • Priority: Visual acuity testing should be performed, but if a chemical is present, irrigation occurs first.

  • Duration: Minimum of $15-30\,minutes$.

  • Technique: Tilt the head toward the affected side to prevent the substance from washing into the unaffected eye. Flush from the inner canthus to the outer canthus. Remove contact lenses first. Use sterile saline or tap water if nothing else is available.

• Ophthalmic Medication Administration

  • Hand Hygiene: Essential before and after.

  • Technique: Gently pull down the lower eyelid and administer medication into the lower conjunctival sac. Do not touch the dropper tip to the eye or skin.

  • Post-Installation: Close the eye for $1-2\,minutes$.

  • Nasolacrimal Occlusion: Apply pressure to the inner corner of the eye for $1-2\,minutes$ to minimize systemic absorption.

  • Ointments: Apply a ribbon-like strip from the inner to the outer canthus. Bedtime is best for ointments due to blurred vision.

  • Timing: Wait $3-5\,minutes$ between drops of the same medication and $10-15\,minutes$ between different medications. Always administer drops before ointments.

Safety, Risk Factors, and Nutrition

• Environmental Modifications

  • Remove clutter and low-lying obstacles.

  • Maintain clear, well-lit walkways with glare-free lighting.

  • Use night lights in hallways and bathrooms.

  • Tactile Markers: Place on stairs or medication containers to help identification by touch.

  • Clock Face Orientation: Used to describe the environment to visually impaired patients (e.g., "your water is at 3:00").

  • Communication: Speak directly to the patient; do not shout as hearing usually remains intact.

• Risk Factors for Eye Disorders

  • Non-modifiable: Aging, genetics, female sex (higher risk for AMD).

  • Modifiable: Diabetes, hypertension, smoking, prolonged UV exposure, prolonged screen time.

  • Medication-Related Risks:

    • Corticosteroids: Prolonged use increases the risk of cataracts and glaucoma.

    • Topiramate: Angle-closure glaucoma.

    • Ethambutol: Optic neuritis (coloration problems).

    • Amiodarone: Optic neuropathy.

    • Hydroxychloroquine: Requires regular eye exams.

• Nutrition for Eye Health

  • Vitamin A: Found in carrots, kale, liver, and sweet potatoes (deficiency causes night blindness).

  • Vitamin C: Citrus fruits, strawberries, bell peppers.

  • Vitamin E: Almonds, spinach, sunflower seeds.

  • Zinc: Oysters, beef, pumpkin seeds.

  • Lutein and Zeaxanthin: Leafy greens and eggs.

  • Omega-3 Fatty Acids: Salmon, flaxseed, and walnuts.

Specific Eye Disorders

• Hyphema

  • Accumulation of blood in the anterior chamber (between cornea and iris).

  • Causes: Blunt trauma, sickle cell disease, or bleeding disorders (hemophilia).

  • Management: Semi-Fowler's position, rigid eye shield, strict bed rest. Avoid activities that increase IOP (bending, straining, coughing, sneezing, heavy lifting). Administer stool softeners to prevent straining.

• Ocular Contusion (Black Eye)

  • Bruising of soft tissue around the orbit.

  • Management: Cold compresses for $15-20\,minutes$, elevate head of bed.

  • Complications to Report: Diplopia (double vision), restricted eye movement, pupil asymmetry.

• Enucleation

  • Surgical removal of the eye (due to cancer or trauma).

  • Management: Monitor for bleeding and infection. Ocular prosthesis is typically fitted within $4-6\,weeks$. Clean with mild soap and warm water.

• Amblyopia (Lazy Eye)

  • Reduced vision in one eye because the brain favors the stronger eye.

  • Treatment: Occlusion therapy (patching the strong eye) or Atropine drops in the strong eye to force use of the weak eye.

• Foreign Bodies

  • Superficial: Irrigate with sterile saline; do not rub. If visible, remove with a moistened cotton applicator.

  • Penetrating: Do NOT attempt to remove. Stabilize the object with a rigid shield (like a paper cup). Patch both eyes to prevent conjugate movement.

• Refractive Errors

  • Myopia: Nearsightedness (can't see far).

  • Hyperopia: Farsightedness (can't see near).

  • Presbyopia: Age-related loss of lens elasticity, beginning around age 40. Patients hold material further away to see clearly.

  • Astigmatism: Blurred vision due to irregular curvature of the cornea or lens.

• Strabismus (Misaligned Eyes)

  • Initial misalignment is normal for infants up to $4\,months$. If it persists beyond this, it must be reported. If untreated, it leads to permanent amblyopia.

Cataracts and Macular Degeneration Detail

• Cataracts

  • Definition: Progressive, painless clouding of the lens.

  • Symptoms: Blurred/dim vision, glare sensitivity, halos around lights, washed-out colors, and milky white pupil (advanced).

  • Surgery (Phacoemulsification): Ultrasound breaks up the lens for removal and replacement.

  • Post-Operative Care: HOB at $30-45\,degrees$. Sleep on the unaffected side. Rigid eye shield at night. Avoid IOP-increasing activities (lifting > $5-10\,pounds$, straining, bending).

  • Warning Signs: Severe pain, nausea/vomiting, flashes of light, or new floaters (signs of retinal detachment).

• Age-Related Macular Degeneration (AMD)

  • Definition: Loss of central vision, which is progressive. Peripheral vision is preserved.

  • Metamorphopsia: A hallmark sign where straight lines appear wavy or distorted.

  • Scotomas: Blind spots in the central visual field.

  • Monitoring: Use of the Amsler Grid for daily self-monitoring of visual changes.

Glaucoma Management

• Types

  • Open-Angle Glaucoma: 90% of cases. Chronic and slow. Results in "tunnel vision" (loss of peripheral vision).

  • Angle-Closure Glaucoma: A medical emergency. Sudden severe eye pain, blurred vision, colored halos, and nausea.

• Medication and Safety

  • Timolol: A beta-blocker eye drop. Requires nasolacrimal occlusion to prevent systemic effects like bradycardia and hypotension.

  • Latanoprost: Increases outflow; may darken iris color.

  • Mannitol: Osmotic diuretic used in emergency angle-closure to reduce IOP.

  • Contraindicated Medications: Patients with glaucoma must avoid anticholinergics (Atropine, Scopolamine), antihistamines (Diphenhydramine), and decongestants (Pseudoephedrine).

• Definition: Glaucoma is a group of eye conditions that damage the optic nerve, often due to high intraocular pressure. This damage can lead to vision loss or even blindness if untreated.

• Signs and Symptoms:

  • Often asymptomatic in the early stages.

  • Gradual loss of peripheral vision, described as "tunnel vision."

  • Halos around lights.

  • Blurred vision, especially in advanced stages.

  • Severe headaches, particularly during acute attacks.

  • Eye redness, especially in cases of angle-closure glaucoma.

  • Nausea and vomiting, which can accompany an acute angle-closure attack.

• Nursing Management:

  • Compliance with Medications: Ensure patients take prescribed eye drops regularly; educate them about the importance of adherence.

  • Technique Training: Teach proper eye drop administration techniques to minimize waste and maximize effectiveness.

  • Monitoring: Regularly assess intraocular pressure and visual acuity during follow-up visits.

  • Patient Education: Provide guidance on glaucoma awareness, the importance of regular eye exams, and risk factors associated with the disease.

  • Lifestyle Modifications: Advice patients on maintaining a healthy diet, engaging in regular exercise, and avoiding excessive sun exposure.

  • Environment: Ensure adequate lighting in living spaces to prevent falls and assess the home for potential hazards due to vision impairment.